In vitro antibacterial activity of levofloxacin against Gram-negative bacteria isolated from canine urinary tract infections: https://doi.org/10.12982/VIS.2026.083
Abstract
Urinary tract infection (UTI) is a common bacterial disease in dogs, and the increasing prevalence of antimicrobial resistance among uropathogens has complicated therapeutic management. This study aimed to evaluate the in vitro antibacterial activity of levofloxacin against Gram-negative bacteria isolated from dogs with UTIs. A total of 284 Gram-negative bacterial isolates were obtained from urine samples of dogs diagnosed with UTIs. Bacterial identification was performed using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS). The in vitro antibacterial activity of levofloxacin was evaluated by determining the Minimum inhibitory concentration (MIC) and Mutant prevention concentration (MPC) using the agar dilution method. Low susceptibility rates were observed among Enterobacterales, including Escherichia coli (E. coli) (26.96%), Klebsiella pneumoniae (K. pneumoniae) (31.37%), and Proteus mirabilis (P. mirabilis) (36.84%), whereas Pseudomonas aeruginosa exhibited higher susceptibility (72.13%). MPC values were consistently higher than MICs, particularly for E. coli, K. pneumoniae, and P. aeruginosa, suggesting an increased risk of resistance selection at high bacterial densities. Pharmacokinetic/pharmacodynamic (PK/PD) analysis indicated that the standard oral dose of levofloxacin (25 mg/kg) is likely effective only against susceptible strains, with P. mirabilis being the only species to achieve both MIC- and MPC-based PK/PD targets.…
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.